Zoetis | ZTS - Cost Of Sales

Stock Price
117.85
Daily Change
-2.14 -1.78%
Monthly
-1.62%
Yearly
-21.14%
Q2 Forecast
114.39

Zoetis reported $743M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Align Technology USD 363.97M 7.48M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Coherus Biosciences USD 4.04M 324K Dec/2025
Dentsply International USD 518M 55M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Henry Schein USD 2.44B 62M Dec/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Illumina USD 400M 49M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
J&J USD 7.97B 689M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
Merck USD 3.32B 531M Dec/2025
Neogen USD 112.2M 5.81M Dec/2025
Pacira USD 54.62M 6.02M Dec/2025
Perrigo USD 747.4M 81.2M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Quest Diagnostics USD 1.93B 27M Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Sanofi EUR 3.76B 344M Dec/2025
Zoetis USD 743M 60M Dec/2025